 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
^ Top
P
Pharmaceutical Polymers 2007: Basel, Switzerland, 20-21 June 2007 - Co... static version printer friendly pdf version
Pharmaceutical Portfolio Management Strategy static version printer friendly
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its ... static version printer friendly pdf version
Pharmaceutical Preparations: State Market Index static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in Canada static version printer friendly
Pharmaceutical Pricing and Reimbursement in China static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in France, 2008 static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in India static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in Italy, 2008 static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in Japan static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in Japan, 2008 static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in the United States static version printer friendly pdf version
Pharmaceutical Pricing and Reimbursement in the United States, 2008 static version printer friendly pdf version
Pharmaceutical Pricing Strategies: Price optimization, reimbursement a... static version printer friendly
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006 static version printer friendly
Pharmaceutical Pricing, Reimbursement Environment in China static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fir... static version printer friendly
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fir... static version printer friendly
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fir... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fir... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fou... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fou... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Sec... static version printer friendly
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Sec... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Sec... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Thi... static version printer friendly
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Thi... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Thi... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Thi... static version printer friendly pdf version
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in ... static version printer friendly
Pharmaceutical Product Launch Evaluation Excellence: Processes & Measu... static version printer friendly pdf version
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012... static version printer friendly pdf version
Pharmaceutical Product Lifecycle Management Forecast in North America ... static version printer friendly pdf version
Pharmaceutical Product Lifecycle Management Forecast in Western Europe... static version printer friendly pdf version
Pharmaceutical Product Manufacturing in Australia static version printer friendly
Pharmaceutical Project and Portfolio Management: Effective Organizatio... static version printer friendly
Pharmaceutical Promotional Effectiveness: Benchmarking Top Tier Compan... static version printer friendly
Pharmaceutical R&D Outsourcing Strategies: An Analysis of Market Drive... static version printer friendly pdf version
Pharmaceutical Raw Materials Manufacturing in China static version printer friendly pdf version
Pharmaceutical Regulatory Affairs in the EU & US static version printer friendly pdf version
Pharmaceutical Research in France - Portfolio Analysis static version printer friendly pdf version
Pharmaceutical Sales Force Effectiveness Strategies: Evaluating Evolvi... static version printer friendly pdf version
Pharmaceutical Sales Force Strategies: Driving ROI Through Best Practi... static version printer friendly
Pharmaceutical Sales Training Groups: Building Better Sales Forces static version printer friendly pdf version
Pharmaceutical Sales Training: Turning New Hires into Top Performers static version printer friendly pdf version
Pharmaceutical Science Exellence: CMC Activities, Resources, and Perfo... static version printer friendly pdf version
Pharmaceutical Speaker Programs: Measuring ROI and Communicating Value... static version printer friendly pdf version
Pharmaceutical Supply Chain Strategies: Reassessing Product Distributi... static version printer friendly pdf version
Pharmaceutical Wholesalers & Distributors (UK) - Portfolio Analysis static version printer friendly pdf version
Pharmaceutical Wholesalers 2002: New Era of Drastic Changes - Japan static version printer friendly pdf version
Pharmaceutical-Related Outsourcing Business 2000 - Japan static version printer friendly
Pharmaceuticals (UK) - Portfolio Analysis static version printer friendly pdf version
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide static version printer friendly pdf version
Pharmaceuticals - Global Group of Eight (G8) Industry Guide static version printer friendly pdf version
Pharmaceuticals - Global Outlook static version printer friendly pdf version
Pharmaceuticals - North America (NAFTA) Industry Guide static version printer friendly pdf version
Pharmaceuticals - Top 5 Emerging Markets Industry Guide static version printer friendly pdf version
Pharmaceuticals 2001: A Year in Review static version printer friendly
Pharmaceuticals and Life Sciences IT Market in Malaysia static version printer friendly pdf version
Pharmaceuticals and Politics: Will Political Opinion Affect the Future... static version printer friendly
Pharmaceuticals and Society: Critical Discourses and Debates static version printer friendly pdf version
Pharmaceuticals in Asia-Pacific static version printer friendly pdf version
Pharmaceuticals in Australia static version printer friendly pdf version
Pharmaceuticals in Belgium static version printer friendly pdf version
Pharmaceuticals in Brazil static version printer friendly pdf version
Pharmaceuticals in Canada static version printer friendly pdf version
Pharmaceuticals in China static version printer friendly
Pharmaceuticals in Denmark static version printer friendly pdf version
Pharmaceuticals in Europe static version printer friendly pdf version
Pharmaceuticals in France static version printer friendly
Pharmaceuticals in France static version printer friendly
Pharmaceuticals in France - Portfolio Analysis static version printer friendly pdf version
Pharmaceuticals in Germany static version printer friendly
Pharmaceuticals in Germany static version printer friendly
Pharmaceuticals in Hungary static version printer friendly pdf version
Pharmaceuticals in India static version printer friendly pdf version
Pharmaceuticals in Italy static version printer friendly
Pharmaceuticals in Japan static version printer friendly
Pharmaceuticals in Mexico static version printer friendly pdf version
Pharmaceuticals in Norway static version printer friendly pdf version
Pharmaceuticals in Poland static version printer friendly pdf version
Pharmaceuticals in Russia static version printer friendly pdf version
Pharmaceuticals in Singapore static version printer friendly pdf version
Pharmaceuticals in South Africa static version printer friendly pdf version
Pharmaceuticals in South Korea static version printer friendly pdf version
Pharmaceuticals in Spain static version printer friendly
Pharmaceuticals in Sweden static version printer friendly pdf version
Pharmaceuticals in Taiwan static version printer friendly pdf version
Pharmaceuticals in the Czech Republic static version printer friendly pdf version
Pharmaceuticals in the Netherlands static version printer friendly
Pharmaceuticals in the UK static version printer friendly
Pharmaceuticals in the United Kingdom static version printer friendly
Pharmaceuticals in the United States static version printer friendly
Pharmaceuticals in the USA static version printer friendly
Pharmaceuticals Manufacture static version printer friendly pdf version
Pharmaceuticals Wholesale in Italy static version printer friendly pdf version
Pharmaceuticals: Asia-Pacific Industry Guide static version printer friendly pdf version
Pharmaceuticals: Belgium Industry Guide static version printer friendly pdf version
Pharmaceuticals: Canada Industry Guide static version printer friendly pdf version
Pharmaceuticals: China Industry Guide static version printer friendly pdf version
Pharmaceuticals: Europe Industry Guide static version printer friendly pdf version
Pharmaceuticals: France Industry Guide static version printer friendly pdf version
Pharmaceuticals: Germany Industry Guide static version printer friendly pdf version
Pharmaceuticals: Global Industry Almanac static version printer friendly pdf version
Pharmaceuticals: Global Industry Guide static version printer friendly
Pharmaceuticals: Italy Industry Guide static version printer friendly pdf version
Pharmaceuticals: Japan Industry Guide static version printer friendly pdf version
Pharmaceuticals: Netherlands Industry Guide static version printer friendly pdf version
Pharmaceuticals: Spain Industry Guide static version printer friendly pdf version
Pharmaceuticals: United Kingdom Industry Guide static version printer friendly pdf version
Pharmaceuticals: United States Industry Guide static version printer friendly pdf version
Pharmaceutics Market 2002-2003 - Japan static version printer friendly
Pharmacies and Drug Retailers in China static version printer friendly pdf version
Pharmacies in Argentina 2006 static version printer friendly
Pharmacies in Australia static version printer friendly pdf version
Pharmacoepidemiology, Fourth Edition static version printer friendly
Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and... static version printer friendly pdf version
Pharmacology for the Health Care Professions static version printer friendly pdf version
Pharmacovigilance: A New Era of Drug Safety static version printer friendly pdf version
Pharmacy Benefit Management Market Overview 2006 static version printer friendly pdf version
Pharmacy Information Systems Markets static version printer friendly pdf version
Pharmacy Retail Market - India static version printer friendly pdf version
PharmaDeals® Deal Making Spotlight on GSK static version printer friendly
PharmaDeals® Deal Making Spotlight on Johnson & Johnson static version printer friendly
PharmaDeals® Deal Making Spotlight on Novartis static version printer friendly pdf version
PharmaHandbook - Argentina static version printer friendly pdf version
PharmaHandbook - Asia Pacific Region static version printer friendly pdf version
PharmaHandbook - Australia static version printer friendly pdf version
PharmaHandbook - Belgium static version printer friendly pdf version
PharmaHandbook - Brazil static version printer friendly pdf version
PharmaHandbook - Canada static version printer friendly pdf version
PharmaHandbook - Chile static version printer friendly pdf version
PharmaHandbook - China static version printer friendly pdf version
PharmaHandbook - Czech Republic static version printer friendly pdf version
PharmaHandbook - Egypt static version printer friendly pdf version
PharmaHandbook - EU Region static version printer friendly pdf version
PharmaHandbook - European Union Overview static version printer friendly pdf version
PharmaHandbook - France static version printer friendly pdf version
PharmaHandbook - Germany static version printer friendly pdf version
PharmaHandbook - Greece static version printer friendly pdf version
PharmaHandbook - Hungary static version printer friendly pdf version
PharmaHandbook - India static version printer friendly pdf version
PharmaHandbook - Indonesia static version printer friendly pdf version
PharmaHandbook - Ireland static version printer friendly pdf version
PharmaHandbook - Israel static version printer friendly pdf version
PharmaHandbook - Italy static version printer friendly pdf version
PharmaHandbook - Japan static version printer friendly pdf version
PharmaHandbook - Korea static version printer friendly pdf version
PharmaHandbook - Latin America Region static version printer friendly pdf version
PharmaHandbook - Mexico static version printer friendly pdf version
PharmaHandbook - Middle East & Africa Region static version printer friendly pdf version
PharmaHandbook - Netherlands static version printer friendly pdf version
PharmaHandbook - New Zealand static version printer friendly pdf version
PharmaHandbook - North America static version printer friendly pdf version
PharmaHandbook - Poland static version printer friendly pdf version
PharmaHandbook - Portugal static version printer friendly pdf version
PharmaHandbook - Romania static version printer friendly pdf version
PharmaHandbook - Russia static version printer friendly pdf version
PharmaHandbook - Saudi Arabia static version printer friendly pdf version
PharmaHandbook - South Africa static version printer friendly pdf version
PharmaHandbook - Spain static version printer friendly pdf version
PharmaHandbook - Sweden static version printer friendly pdf version
PharmaHandbook - Switzerland static version printer friendly pdf version
PharmaHandbook - Taiwan static version printer friendly pdf version
PharmaHandbook - Thailand static version printer friendly pdf version
PharmaHandbook - Turkey static version printer friendly pdf version
PharmaHandbook - UK static version printer friendly pdf version
PharmaHandbook - US static version printer friendly pdf version
PharmaHandbook - Venezuela static version printer friendly pdf version
PharmaHandbook - Vietnam static version printer friendly pdf version
PharmaHandbook 5th Edition static version printer friendly pdf version
PharmaHandbook 6th Edition: A Guide to the International Pharmaceutica... static version printer friendly pdf version
PharmaHandbook 6th Edition: A Guide to the International Pharmaceutica... static version printer friendly pdf version
PharmaHandbook 6th Edition: A Guide to the International Pharmaceutica... static version printer friendly pdf version
PharmaVitae 2002: Alpharma static version printer friendly
PharmaVitae 2002: Andrx Corporation static version printer friendly
PharmaVitae 2002: Antisoma static version printer friendly pdf version
PharmaVitae 2002: Bristol-Myers Squibb static version printer friendly
PharmaVitae 2002: Cambridge Antibody Technology static version printer friendly
PharmaVitae 2002: Celltech static version printer friendly pdf version
PharmaVitae 2002: Dainippon Pharmaceutical Co. static version printer friendly
PharmaVitae 2002: Eli Lilly and Company static version printer friendly
PharmaVitae 2002: Fujisawa Healthcare static version printer friendly pdf version
PharmaVitae 2002: Human Genome Sciences static version printer friendly pdf version
PharmaVitae 2002: Idec static version printer friendly pdf version
PharmaVitae 2002: Ivax static version printer friendly
PharmaVitae 2002: Japan Tobacco static version printer friendly
PharmaVitae 2002: Kirin Brewery static version printer friendly
PharmaVitae 2002: KV Pharmaceuticals static version printer friendly
PharmaVitae 2002: Kyorin Pharmaceutical static version printer friendly
PharmaVitae 2002: MedImmune static version printer friendly pdf version
PharmaVitae 2002: Ranbaxy static version printer friendly
PharmaVitae 2002: Shionogi static version printer friendly pdf version
PharmaVitae 2002: Sicor static version printer friendly
PharmaVitae 2002: Solvay static version printer friendly
PharmaVitae 2002: Sumitomo static version printer friendly
PharmaVitae 2002: Takeda static version printer friendly pdf version
PharmaVitae 2002: Tanabe Seiyaku static version printer friendly
PharmaVitae 2002: Wyeth static version printer friendly
PharmaVitae 2003: MedImmune static version printer friendly pdf version
PharmaVitae 2004: Almirall Global & US Analysis static version printer friendly
PharmaVitae 2004: Almirall Global Analysis static version printer friendly
PharmaVitae 2004: Amgen Global & US Analysis static version printer friendly
PharmaVitae 2004: Amgen Global Analysis static version printer friendly
PharmaVitae 2004: Celltech Global & US Analysis static version printer friendly
PharmaVitae 2004: Celltech Global Analysis static version printer friendly
PharmaVitae 2004: Eisai Global & US Analysis static version printer friendly
PharmaVitae 2004: Eisai Global Analysis static version printer friendly
PharmaVitae 2004: Eli Lilly Global & US Analysis static version printer friendly
PharmaVitae 2004: Eli Lilly Global Analysis static version printer friendly
PharmaVitae 2004: Forest Global & US Analysis static version printer friendly
PharmaVitae 2004: Forest Global Analysis static version printer friendly
PharmaVitae 2004: Fujisawa Global & US Analysis static version printer friendly
PharmaVitae 2004: Fujisawa Global Analysis static version printer friendly
PharmaVitae 2004: Genentech Global Analysis static version printer friendly pdf version
PharmaVitae 2004: Genentech Global and US Analysis static version printer friendly pdf version
PharmaVitae 2004: Genzyme Global & US Analysis static version printer friendly pdf version
PharmaVitae 2004: Genzyme Global Analysis static version printer friendly pdf version
PharmaVitae 2004: Gilead Global Analysis static version printer friendly
PharmaVitae 2004: Ipsen Global & US Analysis static version printer friendly
PharmaVitae 2004: Ipsen Global Analysis static version printer friendly
PharmaVitae 2004: Johnson & Johnson Global & US Analysis static version printer friendly
PharmaVitae 2004: Johnson & Johnson Global Analysis static version printer friendly
PharmaVitae 2004: Novartis Global & US Analysis static version printer friendly
PharmaVitae 2004: Novartis Global Analysis static version printer friendly
PharmaVitae 2004: Pfizer Global & US Analysis static version printer friendly pdf version
PharmaVitae 2004: Pfizer Global Analysis static version printer friendly
PharmaVitae 2004: Sankyo Global & US Analysis static version printer friendly pdf version
Pharmavitae 2004: Sankyo Global Analysis static version printer friendly pdf version
PharmaVitae 2004: Sanofi-Aventis Global & US Analysis static version printer friendly
PharmaVitae 2004: Sanofi-Aventis Global Analysis static version printer friendly pdf version
PharmaVitae 2004: Schwarz Pharma Global & US Analysis static version printer friendly
PharmaVitae 2004: Schwarz Pharma Global Analysis static version printer friendly
PharmaVitae 2004: Serono Global & US Analysis static version printer friendly
PharmaVitae 2004: Serono Global Analysis static version printer friendly
PharmaVitae 2004: Servier Global & US Analysis static version printer friendly
PharmaVitae 2004: Servier Global Analysis static version printer friendly
PharmaVitae 2004: Shionogi Global & US Analysis static version printer friendly
PharmaVitae 2004: Shionogi Global Analysis static version printer friendly
PharmaVitae 2004: Takeda Global & US Analysis static version printer friendly
PharmaVitae 2004: Takeda Global Analysis static version printer friendly
PharmaVitae 2004: Wyeth Global Analysis static version printer friendly
PharmaVitae 2004: Wyeth Global and US Analysis static version printer friendly
PharmaVitae 2005: Amgen Global Analysis static version printer friendly
PharmaVitae 2005: Amgen Global and US Analysis static version printer friendly
Pharmavitae 2005: Bristol-Myers Squibb Global Analysis static version printer friendly pdf version
Pharmavitae 2005: Bristol-Myers Squibb Global And US Analysis static version printer friendly pdf version
PharmaVitae 2005: Genzyme Global Analysis static version printer friendly
PharmaVitae 2005: Genzyme Global and US Analysis static version printer friendly
PharmaVitae 2005: MedImmune Global Analysis static version printer friendly pdf version
PharmaVitae 2005: MedImmune Global and US Analysis static version printer friendly
PharmaVitae 2005: Roche Global Analysis static version printer friendly pdf version
PharmaVitae 2005: Roche Global and US Analysis static version printer friendly pdf version
PharmaVitae Company Comparator Tool static version printer friendly
PharmaVitae Company Comparator Tool - Global and US Analysis static version printer friendly pdf version
PharmaVitae Merger Analysis Tool static version printer friendly
PharmaVitae: Company Comparator Tool static version printer friendly
PharmaWatch Health Round-up static version printer friendly
PharmaWatch: Biotechnology static version printer friendly
PharmaWatch: Cancer static version printer friendly
PharmaWatch: CNS static version printer friendly
PharMerica Corporation Business Intelligence Report static version printer friendly pdf version
Philippines - Pharmaceutical Industry Overview static version printer friendly pdf version
Philippines Phamaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Philippines Pharmaceuticals & Healthcare Report Q3 2007 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Philippines Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics... static version printer friendly
Phosphodiesterases: A Drug Target Family with Broad Therapeutic Impact... static version printer friendly
Physician Perception of Biologics in Autoimmune Disease - Targeted Det... static version printer friendly pdf version
Physician Practice Websites: Strengthening Patient-Physician Relations... static version printer friendly
Physics of Photonic Devices, 2nd Edition static version printer friendly pdf version
Pierre Fabre: PharmaVitae Profile 2005 static version printer friendly
Pioglitazone - Pipeline Developer static version printer friendly pdf version
Pioglitazone - Pipeline Selector static version printer friendly pdf version
Pipeline and Commercial Insight: Hepatitis C - High Unmet Need Drives ... static version printer friendly pdf version
Pipeline and Commercial Perspectives: Psoriasis and Atopic Dermatitis ... static version printer friendly pdf version
Pipeline Insight: Acute Stroke: Commercial Risk Offsets High Unmet Nee... static version printer friendly pdf version
Pipeline Insight: Alzheimers Disease - A Busy Future, with Diagnosis, ... static version printer friendly pdf version
Pipeline Insight: Antiarrhythmics - RSD1235 in a Class of its Own static version printer friendly pdf version
Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fa... static version printer friendly
Pipeline Insight: Antithrombotics - Anticoagulants And Antiplatelets H... static version printer friendly
Pipeline Insight: Asthma, Copd and Allergic Rhinitis - The Needs of Se... static version printer friendly
Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage... static version printer friendly
Pipeline Insight: Asthma/COPD - Targeted Therapies on the Horizon static version printer friendly pdf version
Pipeline Insight: Bipolar Disorder - New Treatments for Bipolar Depres... static version printer friendly pdf version
Pipeline Insight: Depression - Novel Drugs to Grow Third-line Market static version printer friendly pdf version
Pipeline Insight: Depression - Novel therapies key to market penetrati... static version printer friendly pdf version
Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New d... static version printer friendly pdf version
Pipeline Insight: Epilepsy - Pipeline Drugs Struggle to Outshine their... static version printer friendly pdf version
Pipeline Insight: Hepatitis C - Protease inhibitors to drive market ex... static version printer friendly
Pipeline Insight: HIV - Enter the New Generation Inhibitors static version printer friendly
Pipeline Insight: HIV - Extending Treatment Options static version printer friendly pdf version
Pipeline Insight: HIV - The Age of Convenience static version printer friendly pdf version
Pipeline Insight: Innovative Therapies - Targeted therapy, a clinical ... static version printer friendly pdf version
Pipeline Insight: Insulin Antidiabetics - Return to Injections - Alter... static version printer friendly pdf version
Pipeline Insight: Insulins - Inhalable Insulins Unlikely to Become Blo... static version printer friendly pdf version
Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail To Nail Neuro... static version printer friendly pdf version
Pipeline Insight: Nociceptive Pain - Safety Profile Uppermost in Crowd... static version printer friendly
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine? static version printer friendly pdf version
Pipeline Insight: Osteoarthritis - The Wait for a DMOAD Continues static version printer friendly pdf version
Pipeline Insight: Osteoporosis - Intermittent Dosing and Multiple Indi... static version printer friendly
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving f... static version printer friendly pdf version
Pipeline Insight: Substance Dependence - Part I: Nicotine static version printer friendly pdf version
Pipeline Perspectives: Vaccines - Expanding Portfolio Diversity static version printer friendly
Pitavastatin - Pipeline Developer static version printer friendly pdf version
Pitavastatin - Pipeline Selector static version printer friendly pdf version
Poland - Pharmaceutical Industry Overview static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Poland Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Polish Pharmaceutical Report static version printer friendly pdf version
Portfolio Management: Best Practice in Optimizing Resource Allocation static version printer friendly pdf version
Portugal Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Portugal Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Posaconazole - Pipeline Developer static version printer friendly pdf version
Posaconazole - Pipeline Selector static version printer friendly pdf version
Positive Psychology and Family Therapy: Creative Techniques and Practi... static version printer friendly pdf version
Post-ADA Report - Coverage and Analysis of Highlighted Data Presented ... static version printer friendly pdf version
Post-ASCO Report -Coverage and Analysis of Highlighted Data Presented ... static version printer friendly pdf version
Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnost... static version printer friendly
Postpartum Depression - Overcoming Unique Barriers to Treatment static version printer friendly pdf version
Practical Guide to Finding Partners in Pharma and Biotech, 2nd Edition... static version printer friendly pdf version
Practical Hemostasis and Thrombosis, 2nd Edition static version printer friendly pdf version
Practical Teaching in Emergency Medicine static version printer friendly pdf version
Pramipexole - Pipeline Developer static version printer friendly pdf version
Pramipexole - Pipeline Selector static version printer friendly pdf version
Prasugrel - Pipeline Developer static version printer friendly pdf version
Prasugrel - Pipeline Selector static version printer friendly pdf version
Pravastatin - Pipeline Developer static version printer friendly pdf version
Pravastatin - Pipeline Selector static version printer friendly pdf version
Pre-clinical Stage Partnering Agreements in Biopharma static version printer friendly pdf version
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Ta... static version printer friendly pdf version
Prediction of Protein Structures, Functions, and Interactions static version printer friendly pdf version
Predictive ADME and Toxicology Strategies: Challenges and Opportunitie... static version printer friendly pdf version
Pregabalin - Pipeline Developer static version printer friendly pdf version
Pregabalin - Pipeline Selector static version printer friendly pdf version
Prescribing for Elderly Patients static version printer friendly pdf version
Prescription Drug Counterfeiting static version printer friendly pdf version
Prescription Drug Wholesaling in the US static version printer friendly pdf version
Prescription Drugs - Global Strategic Business Report static version printer friendly pdf version
Prescription Drugs: Global Outlook to 2008 static version printer friendly pdf version
Prescription for Drug Alternatives: All-Natural Options for Better Hea... static version printer friendly pdf version
Prevention of Organ Transplant Rejection: Current Therapies and Novel ... static version printer friendly
Price of a Typical Prescription of One of the Top 10 Drugs in the U.S.... static version printer friendly
Pricing & Reimbursement in Asia-Pacific static version printer friendly pdf version
Pricing & Reimbursement in Europe: Can the Drive for Cost Effectivenes... static version printer friendly pdf version
Pricing and Reimbursement Environment for Immune Disease Therapies static version printer friendly pdf version
Pricing and Reimbursement in Key Asia Pacific Markets static version printer friendly pdf version
Pricing and Reimbursement in the United Arab Emirates static version printer friendly pdf version
Pricing and Reimbursement in the US: Innovation and Robust Pharmacoeco... static version printer friendly
Pricing and Reimbursement Issues for Pharmaceutical Products in Europe... static version printer friendly pdf version
Pricing and Reimbursement Issues in Psychiatry static version printer friendly pdf version
Pricing and Reimbursement Risk and Opportunities in Pharmaceutical Dea... static version printer friendly pdf version
Pricing Drivers Of Combination Therapies: Product Premiums Scarcely Se... static version printer friendly
Pricing: Obtaining the Optimal Price to Maximize Profits static version printer friendly pdf version
Principles and Practice of Pharmacology for Anaesthetists, 5th Edition... static version printer friendly pdf version
Prions: A Primer for the Biopharmaceutical Industry static version printer friendly pdf version
Process Scale Purification of Antibodies static version printer friendly pdf version
Product and Asset Purchase Agreements in Pharma, Biotech and Diagnosti... static version printer friendly pdf version
Product Commercialization Excellence: Preparation and Management of Fi... static version printer friendly pdf version
Product Life Spans: Trends in the Quality and Staying Power of New Pro... static version printer friendly pdf version
Product Pinpoint: The New Vaccines static version printer friendly pdf version
Product Relaunch Excellence: Transforming Lackluster Pharmaceutical Pr... static version printer friendly pdf version
Production & Market of Glucosamine in China static version printer friendly pdf version
Production, market and benchmarking of Carnitine in China static version printer friendly pdf version
Produits Pharmaceutiques - Fabricants en France - Analyse de Portefeui... static version printer friendly pdf version
Produits Pharmaceutiques en France - Analyse de Portefeuille Plimsoll static version printer friendly pdf version
Profitable Partnerships: Developing Excellence in Alliances static version printer friendly pdf version
Progress in RNA-Based Therapeutics static version printer friendly
Progress in the Treatment and Understanding of Restless Legs Syndrome ... static version printer friendly
Progress Report on the Medicare Prescription Drug Benefit static version printer friendly
Project Management for the Pharmaceutical Industry static version printer friendly
Prospective Payment Systems: Opportunities and Threats for the Pharmac... static version printer friendly pdf version
Prospects for Legalizing Drug (Re-)Importation to the United States static version printer friendly pdf version
Prospects for Major Japanese Pharma Companies to 2010 static version printer friendly
Prospects for Pharmaceutical Wholesalers 1999 - Japan static version printer friendly pdf version
Prospects for Pharmaceutical Wholesalers 2001 - Japan static version printer friendly
Prospects for Unified Pharmaceutical Prices in Europe static version printer friendly
Prospering in a Down Market: Strategies for Life Science Suppliers static version printer friendly pdf version
Protein-Protein Interactions as Drug Targets- Focusing On Cell Circuit... static version printer friendly
Protein-Protein Interactions: Are They Now Druggable Targets? static version printer friendly
Psoriasis - Biologics are Yet to Make Topical Treatments Obsolete static version printer friendly pdf version
Psoriasis - Biologics Impact Treatment Regimes Across The Globe static version printer friendly pdf version
Psychopharmacotherapy Market Insights: Obstacles and Opportunities in ... static version printer friendly pdf version
Public Relations Excellence: Using PR to Launch, Grow, and Extend Your... static version printer friendly pdf version
Puerto Rico Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Puerto Rico Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Puerto Rico Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Puerto Rico Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Pulmonary Drug Delivery Technologies - Global Strategic Business Repor... static version printer friendly pdf version
Putting Promotion in Perspective: Part I--A Strategic Overview static version printer friendly
Putting Promotion in Perspective: Part II--Timing, Mix, and Impact static version printer friendly
Pyriproxyfen (Vet) - Pipeline Developer static version printer friendly pdf version
Pyriproxyfen (Vet) - Pipeline Selector static version printer friendly pdf version
^ Top
Q
Qatar Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Qatar Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Qatar Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Quality by Design for Biopharmaceuticals: Principles and Case Studies static version printer friendly pdf version
Quality Systems and Controls for Pharmaceuticals static version printer friendly pdf version
Quantitative Analysis of Global Biopharmaceutical Manufacturing static version printer friendly pdf version
Quetiapine - Pipeline Developer static version printer friendly pdf version
Quetiapine - Pipeline Selector static version printer friendly pdf version
Quinapril - Pipeline Developer static version printer friendly pdf version
Quinapril - Pipeline Selector static version printer friendly pdf version
^ Top
R
R& D of Pharmaceutical Companies 2001 - Japan static version printer friendly pdf version
R&D Productivity - Measures of Success in the Pharmaceutical Industry static version printer friendly pdf version
Rabeprazole - Pipeline Developer static version printer friendly pdf version
Rabeprazole - Pipeline Selector static version printer friendly pdf version
Ractopamine (Vet) - Pipeline Developer static version printer friendly pdf version
Ractopamine (Vet) - Pipeline Selector static version printer friendly pdf version
Radiopharmaceuticals - A US and European Market Analysis static version printer friendly pdf version
Radiopharmaceuticals - Global Strategic Business Report static version printer friendly pdf version
Radiosensitizers: A Market Sensitive to Change? static version printer friendly
Raloxifene - Pipeline Developer static version printer friendly pdf version
Raloxifene - Pipeline Selector static version printer friendly pdf version
Ramelteon - Pipeline Developer static version printer friendly pdf version
Ramelteon - Pipeline Selector static version printer friendly pdf version
Ramipril - Pipeline Developer static version printer friendly pdf version
Ramipril - Pipeline Selector static version printer friendly pdf version
Rapid Review of Medicine in Old Age static version printer friendly pdf version
Rapid Test Kits for Patient Diagnostics static version printer friendly pdf version
Rasagiline - Pipeline Developer static version printer friendly pdf version
Rasagiline - Pipeline Selector static version printer friendly pdf version
Rate of False Positive Mammograms static version printer friendly pdf version
Rate of Leading Causes of New Cases and Deaths of Cancer in Men and Wo... static version printer friendly pdf version
Rate of New Cases and Deaths of Cancer Among Women in the U.S., 2008 static version printer friendly pdf version
Rate of New Cases and Deaths of Cervical Cancer by Age Group Worldwide... static version printer friendly pdf version
Rate of New Hepatitis A, Hepatitis B and Hepatitis C Infections, 1982-... static version printer friendly pdf version
Reaching Cardiologists Online: Overcoming Skepticism Through Service Q... static version printer friendly
Reaching Endocrinologists Online: Strategies for Building Brand Equity... static version printer friendly pdf version
Reaching Oncologists Online: Aligning Online Marketing Strategies with... static version printer friendly
Reactions to Genetically Modified (GM) Foods static version printer friendly
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNA... static version printer friendly pdf version
Reboxetine - Pipeline Developer static version printer friendly pdf version
Reboxetine - Pipeline Selector static version printer friendly pdf version
Recent HMO Pharmacy Trends static version printer friendly
Recherches Pharmaceutiques en France - Analyse de Portefeuille Plimsol... static version printer friendly pdf version
Regenerative Medicine - Global Market Trends static version printer friendly pdf version
Regenerative Medicine - Global Strategic Business Report static version printer friendly
Regional Hospital Institutions: Impacts on Hospital Consumption static version printer friendly
Regulations in Global Pharma Industry static version printer friendly
Reinventing Patient Recruitment static version printer friendly pdf version
Reinventing Pharmaceutical Sales Forces static version printer friendly pdf version
Relaxin and Related Peptides static version printer friendly pdf version
Repaglinide - Pipeline Developer static version printer friendly pdf version
Repaglinide - Pipeline Selector static version printer friendly pdf version
Report of the Development of Medicine Circulation Industry in China static version printer friendly
Report of Traditional Chinese Medicine Industry under, 2009 static version printer friendly pdf version
Report on Antihypertensive Drug Market static version printer friendly pdf version
Report on China Pharmaceutical Machinery Market static version printer friendly pdf version
Report on China's Anti-fungal Drug Industry static version printer friendly pdf version
Report on China’s Anti-Asthma Drug Market static version printer friendly
Report on China’s Anti-Asthma Medicine Market static version printer friendly pdf version
Report on China’s Benign Prostate Hyperplasia Medicine Market static version printer friendly
Report on China’s Oral Contraceptive Drugs Industry static version printer friendly pdf version
Report On China’s Respiratory System Medicine Market static version printer friendly pdf version
Report on Chinas Anti-fungal Drug Industry static version printer friendly pdf version
Report on Chinas Pharmaceutical Machinery Market static version printer friendly
Report on Core Competitiveness and Positioning of Chinese Medicine Ret... static version printer friendly
Report on the Core Competitiveness and Positioning of Chinese Medicine... static version printer friendly
Requip Case Study: Life Cycle Management - Reinvigorating a Mature Bra... static version printer friendly pdf version
Research in the Import & Export Trade of China’s Crude Drug static version printer friendly pdf version
Research Report in Vaccine Industry static version printer friendly pdf version
Research Report of China's Cold Medicine Market static version printer friendly pdf version
Research Report of China's Pharmaceutical Necessities Industry static version printer friendly pdf version
Research Report of China's Traditional Chinese Medicine Formula Granul... static version printer friendly pdf version
Research Report of China’s Retail Pharmacy Market static version printer friendly pdf version
Research Report of Chinese Off-patent Drug Market, 2009 static version printer friendly pdf version
Research Report of Mergers and Acquisitions in Chinese Medical Circula... static version printer friendly pdf version
Research Report of the Third Terminal Market of Chinese Medinces, 2009... static version printer friendly pdf version
Research Report on China's Anti-HBV Drug Market static version printer friendly pdf version
Research Report on China's Biopharmaceutical Industry, 2009 static version printer friendly pdf version
Research Report on China's Treatment Drug of Cerebrovascular Disease static version printer friendly pdf version
Research Report on Chinese Anti-Tumor Drug Market, 2009 static version printer friendly pdf version
Research Report on Chinese Avermectin Industry, 2009-2010 static version printer friendly pdf version
Research Report on Chinese Chemical Pharmaceuticals Industry, 2009 static version printer friendly pdf version
Respiratory Handbook 2005-15: Novartis Moving Into the Major League static version printer friendly pdf version
Restless Legs Syndrome - Novel Drugs to Prosper as Lifecycle Managemen... static version printer friendly pdf version
Retail Chemists & Drugstores Market Report 2006 static version printer friendly pdf version
Retail Chemists & Drugstores Market Report 2008 static version printer friendly pdf version
Retail Chemists in France - Portfolio Analysis static version printer friendly pdf version
Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Pa... static version printer friendly pdf version
RFID for Healthcare and Pharmaceuticals 2009-2019 static version printer friendly pdf version
Rheumatoid Arthritis: Market Trends and R&D Insights static version printer friendly pdf version
Rhodia: Performance, Capabilities, Goals and Strategies in the Worldwi... static version printer friendly pdf version
Riluzole - Pipeline Developer static version printer friendly pdf version
Riluzole - Pipeline Selector static version printer friendly pdf version
Rimonabant - Pipeline Developer static version printer friendly pdf version
Rimonabant - Pipeline Selector static version printer friendly pdf version
Risedronic Acid - Pipeline Developer static version printer friendly pdf version
Risedronic Acid - Pipeline Selector static version printer friendly pdf version
Risperidone - Pipeline Developer static version printer friendly pdf version
Risperidone - Pipeline Selector static version printer friendly pdf version
Ritonavir - Pipeline Developer static version printer friendly pdf version
Ritonavir - Pipeline Selector static version printer friendly pdf version
Rituximab - Pipeline Selector static version printer friendly pdf version
Rivastigmine - Pipeline Developer static version printer friendly pdf version
Rivastigmine - Pipeline Selector static version printer friendly pdf version
Rizatriptan - Pipeline Developer static version printer friendly pdf version
Rizatriptan - Pipeline Selector static version printer friendly pdf version
RNA Interference for Drug R&D: Applications, Alliances, Companies and ... static version printer friendly pdf version
RNAi: Broad Application, Expansive Opportunity, 2nd Edition static version printer friendly pdf version
Robotic Surgery Market Report: 2009 Edition static version printer friendly pdf version
Roche: Performance, Capabilities, Goals and Strategies in the Worldwid... static version printer friendly pdf version
Rocuronium Bromide - Pipeline Selector static version printer friendly pdf version
Romania - Pharmaceutical Industry Overview static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Romania Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Ropinirole - Pipeline Developer static version printer friendly pdf version
Ropinirole - Pipeline Selector static version printer friendly pdf version
Ropivacaine - Pipeline Developer static version printer friendly pdf version
Ropivacaine - Pipeline Selector static version printer friendly pdf version
Rosiglitazone - Pipeline Developer static version printer friendly pdf version
Rosiglitazone - Pipeline Selector static version printer friendly pdf version
Rosuvastatin - Pipeline Developer static version printer friendly pdf version
Rosuvastatin - Pipeline Selector static version printer friendly pdf version
Roxithromycin - Pipeline Developer static version printer friendly pdf version
Roxithromycin - Pipeline Selector static version printer friendly pdf version
Royalty Financing Agreements in Pharma, Biotech and Diagnostics static version printer friendly pdf version
Royalty Rates for Pharmaceuticals & Biotechnology 6th Edition static version printer friendly pdf version
RSNA Radiologist Survey 2006: US & European PACS static version printer friendly pdf version
Running in the Never-ending Race against Healthcare Fraud (Strategic F... static version printer friendly pdf version
Russia - Pharmaceutical Industry Overview static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Russia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Rx-To-OTC Switching Strategies: Lifecycle Management and Building Bran... static version printer friendly pdf version
^ Top
S
Sabinsa Case Study: Successfully Marketing Weight-Loss Supplements static version printer friendly pdf version
Sales Force Strategies in Oncology static version printer friendly pdf version
Sales Force Structures and Strategies 2001: A Case Study Analysis of E... static version printer friendly
Salmeterol - Pipeline Developer static version printer friendly pdf version
Salmeterol - Pipeline Selector static version printer friendly pdf version
Sanofi-Aventis: Performance, Capabilities, Goals and Strategies in the... static version printer friendly pdf version
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Schizophrenia Market: Novel Agents May Establish New Leaders static version printer friendly pdf version
Scientific and Medical Journals on the Web static version printer friendly pdf version
Scientific Publications Strategy: Managing Reputation, Clinical Trial ... static version printer friendly pdf version
Scrip R&D Databook 2006 static version printer friendly pdf version
Scrip Yearbook 2007: 23rd Edition (2 Volumes) static version printer friendly pdf version
Scrip Yearbook 2008: 24th Edition static version printer friendly pdf version
Scrips Pharmaceutical Company League Tables 2007 static version printer friendly pdf version
Sector Snapshot: Anti-Aging Products and Services static version printer friendly pdf version
Sector Snapshot: Prescription Ophthalmic Drug Market static version printer friendly pdf version
Sector Snapshot: Robotics and Orthopedic Surgery static version printer friendly pdf version
Sector Snapshot: Statin Drug Markets static version printer friendly pdf version
Sector Snapshot: Therapeutic Drug Market for Acne static version printer friendly
Sector Snapshot: Therapeutic Radiopharmaceuticals Markets static version printer friendly pdf version
Sector Snapshot: U.S. Market for Gastrointestinal Pharmaceuticals static version printer friendly pdf version
Sector Snapshot: Urinary Incontinence Markets static version printer friendly pdf version
Sector Snapshot: World Pharmaceutical Drug Market static version printer friendly pdf version
Sector Snapshot: Worldwide Psychotherapeutic Drug Market static version printer friendly pdf version
Select Herpes Viruses and Human Papilloma Virus - Non-biologic Interve... static version printer friendly pdf version
Selling enterprise applications and services into the Healthcare / Pha... static version printer friendly
Sepsis - Under Reaction to an Overreaction static version printer friendly
Serbia Phamaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Serbia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Serbia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Serbia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Serbia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Serbia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Sertraline - Pipeline Developer static version printer friendly pdf version
Sertraline - Pipeline Selector static version printer friendly pdf version
Serving the Healthcare Needs of Employers: Employer Market Strategies ... static version printer friendly pdf version
Serving the Needs of the Medicaid Population in Disease Management Pro... static version printer friendly
Sevelamer - Pipeline Developer static version printer friendly pdf version
Sevelamer - Pipeline Selector static version printer friendly pdf version
Shape New Markets: Sepsis static version printer friendly pdf version
Short Protocols in Neuroscience: Systems and Behavioral Method static version printer friendly pdf version
Short Protocols in Pharmacology and Drug Discovery static version printer friendly pdf version
Sibutramine - Pipeline Selector static version printer friendly pdf version
Side Effects of Male Cancers - Better Survival and Growing Social Acce... static version printer friendly pdf version
Sildenafil - Pipeline Developer static version printer friendly pdf version
Sildenafil - Pipeline Selector static version printer friendly pdf version
Simstar And RXVP Case Studies: Providing Compliance Services To Pharma... static version printer friendly
Simvastatin - Pipeline Developer static version printer friendly pdf version
Simvastatin - Pipeline Selector static version printer friendly pdf version
Singapore - Pharmaceutical Industry Overview static version printer friendly pdf version
Singapore Phamaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Singapore Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Singapore Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Singapore Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Singapore Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Singapore Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Singaporean Pharmaceuticals and Life Sciences IT Market static version printer friendly pdf version
Sinusitis: Unmet need and opportunity static version printer friendly
Sirolimus - Pipeline Developer static version printer friendly pdf version
Sirolimus - Pipeline Selector static version printer friendly pdf version
Sitagliptin - Pipeline Developer static version printer friendly pdf version
Sitagliptin - Pipeline Selector static version printer friendly pdf version
Size Estimation Charts static version printer friendly pdf version
Sjogren's Syndrome: Too many patients to ignore static version printer friendly
Skin Lighteners - Global Strategic Business Report static version printer friendly pdf version
Sleeplessness Rate by Age Group in the U.S., 1998-2006 static version printer friendly pdf version
Slentrol Case Study: Using Integrated PR Tactics to Support a Product ... static version printer friendly pdf version
Slimming Market - Market Assessment 2007 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Slovakia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Slovenia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Small & Specialty Drug Branding: Tapping Niche Market Potential static version printer friendly
Small Molecule Kinase Inhibitors - Global Strategic Business Report static version printer friendly pdf version
Snapshots Argentina Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Australia Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Brazil Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Brazil Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Bulgaria Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Canada Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Chile Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots China Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Czech Republic Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Denmark Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots France Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Germany Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Hungary Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots India Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots India Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Italy Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Japan Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Japan Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Mexico Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Mexico Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Poland Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Portugal Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Slovak Republic Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Spain Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Spain Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Sweden Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Thailand Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots Turkey Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots UK OTC Pharmaceuticals 2009 static version printer friendly pdf version
Snapshots UK Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots Ukraine Pharmaceuticals 2007 static version printer friendly pdf version
Snapshots Ukraine Pharmaceuticals 2008 static version printer friendly pdf version
Snapshots US Prescription Pharmaceuticals 2008 static version printer friendly pdf version
Solifenacin - Pipeline Developer static version printer friendly pdf version
Solifenacin - Pipeline Selector static version printer friendly pdf version
Solvay: PharmaVitae Profile static version printer friendly pdf version
Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects... static version printer friendly pdf version
Sorafenib - Pipeline Developer static version printer friendly pdf version
Sorafenib - Pipeline Selector static version printer friendly pdf version
South Africa - Pharmaceutical Industry Overview static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
South Africa Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
South and Central America Active Pharmaceutical Ingredients Market Ana... static version printer friendly pdf version
South Korea - Pharmaceutical Industry Overview static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
South Korea Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Spain Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Spain Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
SPECIAL REPORT: 2007 Industry Dynamics-Lessons Learned static version printer friendly pdf version
Special Report: 2009 Chartbook of International Pharmaceutical Prices static version printer friendly pdf version
SPECIAL REPORT: Blockbusters Then and Now - Trends for Billion-Dollar ... static version printer friendly pdf version
Special Report: Can Innovation Supplant Convention in Sarcoidosis Trea... static version printer friendly pdf version
SPECIAL REPORT: How Will the Withdrawal of Generic Albuterol Change th... static version printer friendly pdf version
SPECIAL REPORT: Lessons Learned in the Pharma Industry, 2008 static version printer friendly pdf version
Special Report: Pharmaceutical Pricing and Reimbursement in Germany, 2... static version printer friendly pdf version
Special Report: State of the Pharmaceutical Industry, 2009 static version printer friendly pdf version
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunit... static version printer friendly pdf version
Special Report: Understanding Treatment Dynamics and Needs in Juvenile... static version printer friendly pdf version
Specialty Pharma: Guide to Success at the New Frontier static version printer friendly pdf version
Specialty Pharmaceuticals - Overview And Trends static version printer friendly pdf version
Specialty Pharmaceuticals in the United States: Changing Patterns of D... static version printer friendly pdf version
Specialty Pharmacies Market Overview 2006 static version printer friendly pdf version
Spectrum Quarterly Deal Review - Fourth Quarter 2005 static version printer friendly pdf version
Stada Arzneimittel Generics Company Intelligence Report static version printer friendly
Stakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxi... static version printer friendly pdf version
Stakeholder Insight: ADHD - Prescriber Attention Still Held by Short A... static version printer friendly
Stakeholder Insight: Atrial Fibrillation - Future Advances in Stroke P... static version printer friendly
Stakeholder Insight: Bipolar Disorders - Zyprexa Sets the Mood for Rev... static version printer friendly pdf version
Stakeholder Insight: Dyslipidemia - Titration versus Combination Thera... static version printer friendly
Stakeholder Insight: Hepatitis B & C - Winning Battles But Not The War... static version printer friendly
Stakeholder Insight: Infertility - Undifferentiated Drugs Force need t... static version printer friendly pdf version
Stakeholder Insight: Inflammatory Bowel Disease - Debate over early ag... static version printer friendly pdf version
Stakeholder Insight: Inflammatory Bowel Disease - Efficacy and Complia... static version printer friendly
Stakeholder Insight: Invasive Fungal Infections - Options Outweigh Rep... static version printer friendly pdf version
Stakeholder Insight: Local and Locally Advanced Prostate Cancer static version printer friendly
Stakeholder Insight: Metabolic Syndrome - Ticking Time Bomb static version printer friendly
Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer... static version printer friendly
Stakeholder Insight: Prostate Cancer Treatment and Commercial Issues static version printer friendly
Stakeholder Insight: Prostate Cancer Treatment in the USA static version printer friendly
Stakeholder Insight: Rheumatoid Arthritis - Biologics Battle Up the Tr... static version printer friendly pdf version
Stakeholder Opinions: Alpha 1 Antitrypsin Deficiency static version printer friendly pdf version
Stakeholder Opinions: Bone Metastases - Impending Patent Expiries May ... static version printer friendly pdf version
Stakeholder Opinions: Cystic Fibrosis static version printer friendly
Stakeholder Opinions: Diagnostics in Neurology - Predictive Biomarkers... static version printer friendly pdf version
Stakeholder Opinions: Hepatocellular Carcinoma - Growing Market Seeks ... static version printer friendly
Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes static version printer friendly
Stakeholder Opinions: Hormonal Contraceptives - New directions in a co... static version printer friendly pdf version
Stakeholder Opinions: Migraine - Lots of Experience, But Less Expertis... static version printer friendly
Stakeholder Opinions: Ovarian Cancer Growing Importance as Secondary I... static version printer friendly pdf version
Stakeholder Opinions: Renal Cell Carcinoma - Novel Targeted Treatments... static version printer friendly
Stakeholder Opinions: Urinary Tract Infections - Ciprofloxacin Leads t... static version printer friendly
Stakeholder Perspectives: Liver Fibrosis/Cirrhosis - Point of No Retur... static version printer friendly
Stakeholder Perspectives: Pulmonary Arterial Hypertension - A Small Ma... static version printer friendly
State Activities: Impact on the U.S. Pharmaceutical Industry static version printer friendly pdf version
State of the Clinical Trials Industry, 2009 static version printer friendly pdf version
State of the Pharmaceutical Industry, 2008 static version printer friendly pdf version
State-by-State Clinical Trial Requirements Reference Guide 2007 static version printer friendly pdf version
Statin Adjunct Therapy - Zetia, Revenue Protection for Zocor? static version printer friendly
Statistical Analysis of Designed Experiments: Theory and Applications static version printer friendly pdf version
Strategic Alliances in World Pharma and Biotech Markets static version printer friendly pdf version
Strategic Analysis - U.S. Data Mining and Predictive Analytics Markets... static version printer friendly pdf version
Strategic Analysis of Biomarkers in Clinical Trials static version printer friendly pdf version
Strategic Analysis of Downstream Processing in Biopharmaceutical Produ... static version printer friendly pdf version
Strategic Analysis of Global Scientific Business Intelligence (Sci-BI)... static version printer friendly pdf version
Strategic Analysis of Opportunities in the CRO Market - Phase 0 static version printer friendly pdf version
Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in... static version printer friendly pdf version
Strategic Analysis of Pharmaceutical Excipients Market in Europe static version printer friendly pdf version
Strategic Analysis of the ADME/TOX Technologies Market in Europe static version printer friendly pdf version
Strategic Analysis of the Automation and Software Solutions in the Wor... static version printer friendly pdf version
Strategic Analysis of the eDetailing Market in the Pharmaceutical Indu... static version printer friendly pdf version
Strategic Analysis of the European Polyols Market static version printer friendly pdf version
Strategic Analysis of the European Specialty Pharma Market static version printer friendly pdf version
Strategic Analysis of the Kenyan Hypertension Markets static version printer friendly pdf version
Strategic Analysis of the North American Probiotics Markets: Human Nut... static version printer friendly pdf version
Strategic Analysis of the Therapeutic Peptide Market in Europe static version printer friendly pdf version
Strategic Analysis of the U.S. Biopharmaceuticals Market static version printer friendly pdf version
Strategic Analysis of the U.S. Enteral Nutrition Markets static version printer friendly pdf version
Strategic Analysis of the World Pediatric Pharmaceuticals Markets static version printer friendly pdf version
Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing Service M... static version printer friendly pdf version
Strategic Analysis of World Combinatorial Chemistry Markets static version printer friendly pdf version
Strategic Clinical Sourcing: Managing Costs and CROs static version printer friendly pdf version
Strategic Overview of Pharmaceutical Pricing and Reimbursement in the ... static version printer friendly pdf version
Strategic Overview of Spondyloarthropathies: Tapping the Market Opport... static version printer friendly pdf version
Strategic Perspectives 2001 Phobias: Patient Barriers to Antidepressan... static version printer friendly
Strategic Perspectives 2001: Antidepressant Treatment Strategies - Eff... static version printer friendly
Strategic Perspectives 2001: Diabetes - Importance of Compliance in Dr... static version printer friendly
Strategic Perspectives 2001: Panic Disorder - Opportunities For Antide... static version printer friendly
Strategic Perspectives 2001: Post Traumatic Stress Disorder - Commerci... static version printer friendly
Strategic Perspectives 2001: Premenstrual Dysphoric Disorder - A Targe... static version printer friendly pdf version
Strategic Perspectives 2002: Endometriosis static version printer friendly
Strategic Perspectives 2002: Herpes static version printer friendly
Strategic Perspectives: Antidyslipidemics - Current Market is not Cond... static version printer friendly pdf version
Strategic Perspectives: Clinical Trial Recruitment in Women's Health- ... static version printer friendly
Strategic Perspectives: CNS Disorders in Women - Premenstrual Syndrome... static version printer friendly
Strategic Perspectives: CNS Portfolio Analysis - The Commercial Opport... static version printer friendly
Strategic Perspectives: Female Sexual Dysfunction - Are Physicians and... static version printer friendly
Strategic Perspectives: Hepatitis B and C - Strategic Developments in ... static version printer friendly
Strategic Perspectives: Hepatocellular Carcinoma: T67 and Thymitaq to ... static version printer friendly
Strategic Perspectives: Malignant Melanoma - Biotechnology-Driven Agen... static version printer friendly
Strategic Perspectives: Pancreatic Cancer - Gemcitabine Combination Th... static version printer friendly
Strategic Perspectives: Parkinson’s Disease - New Treatment Strategies... static version printer friendly
Strategic Perspectives: Prostate Cancer - Issues in Second-line, Brach... static version printer friendly
Strategic Perspectives: The Hospital Antibacterial Market - Defining a... static version printer friendly
Strategies and Tactics for Successful Partnering static version printer friendly
Strategies And Tactics That Improve Patient Recruitment and Retention ... static version printer friendly
Strategies for Building Early-Stage Pharmaceutical Pipelines Through E... static version printer friendly pdf version
Strategies for Drug Target Identification and Validation static version printer friendly pdf version
Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through... static version printer friendly pdf version
Streamlining Information in the Pharmaceutical Industry with Product L... static version printer friendly pdf version
Stroke: Treatments and Prescribing Practices - A Global Survey 2009 static version printer friendly pdf version
Substance Abuse - Alcoholism Drug Pipeline Report static version printer friendly pdf version
|
|